Blocking the Secretion of Hepatic Very Low Density Lipoproteins Renders the Liver More Susceptible to Toxin-induced Injury
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Recently, we generated mice lacking microsomal triglyceride transfer protein (MTP) in the liver (Mttp(Delta/Delta)) and demonstrated that very low density lipoprotein secretion from hepatocytes was almost completely blocked. The blockade in lipoprotein production was accompanied by mild to moderate hepatic steatosis, but the mice appeared healthy. Although hepatic MTP deficiency appeared to be innocuous, we hypothesized that a blockade in very low density lipoprotein secretion and the accompanying steatosis might increase the sensitivity of Mttp(Delta/Delta) livers to additional hepatic insults. To address this issue, we compared the susceptibility of Mttp(Delta/Delta) mice and Mttp(flox/flox) controls to hepatic injury from Escherichia coli lipopolysaccharides, concanavalin A, and Pseudomonas aeruginosa exotoxin A. At baseline, neither the Mttp(Delta/Delta) nor the Mttp(flox/flox) mice had elevated serum transaminases or histologic evidence of hepatic inflammation. After the administration of the toxins, however, the Mttp(Delta/Delta) mice manifested higher levels of transaminases and, unlike the Mttp(flox/flox) mice, developed histologic evidence of hepatic inflammation. The toxic challenge induced tumor necrosis factor-alpha to a similar extent in Mttp(Delta/Delta) and Mttp(flox/flox) mice, but other parameters of injury (e.g. chemokine transcript levels and lipid peroxides) were disproportionately increased in the Mttp(Delta/Delta) mice. Our results suggest that blocking lipoprotein secretion in the liver may increase the susceptibility of the liver to certain toxic challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Unsaturated Fatty Acids Down-regulate SREBP Isoforms 1a and 1c by Two Mechanisms in HEK-293 Cells
Hannah, V. C., Ou, J., Luong, A., Goldstein, J. L., & Brown, M. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007273200 · Cited by 448
Alcoholic liver disease: New insights in pathogenesis lead to new treatments
Lieber, C. S. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80420-1 · Cited by 260
The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver
Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000953200 · Cited by 223
Self-citation
Research works printed but not linked: 60
- Gordon, 1995, Trends Cell Biol., 5, 317, 10.1016/S0962-8924(00)89054-6 · DOI
- Jamil, 1998, J. Lipid Res., 39, 1448, 10.1016/S0022-2275(20)32526-8 · DOI
- van Greevenbroek, 1998, J. Lipid Res., 39, 173, 10.1016/S0022-2275(20)34213-9 · DOI
- Raabe, 1998, Proc. Natl. Acad. Sci. U. S. A., 95, 8686, 10.1073/pnas.95.15.8686 · DOI · Paper page
- Raabe, 1999, J. Clin. Invest., 103, 1287, 10.1172/JCI6576 · DOI · Paper page
- Wetterau, 1998, Science, 282, 751, 10.1126/science.282.5389.751 · DOI · Paper page
- Diehl, 1999, Semin. Liver Dis., 19, 221, 10.1055/s-2007-1007111 · DOI · Paper page
- Tsukamoto, 2001, FASEB J., 15, 1335, 10.1096/fj.00-0650rev · DOI · Paper page
- Partin, 1974, Gastroenterology, 67, 107, 10.1016/S0016-5085(19)32931-2 · DOI
- Illingworth, 1980, Arch. Neurol., 37, 659, 10.1001/archneur.1980.00500590083015 · DOI
- Berg, 1999, Adv. Exp. Med. Biol., 473, 11, 10.1007/978-1-4615-4143-1_2 · DOI · Paper page
- Chitturi, 2001, Semin. Liver Dis., 21, 27, 10.1055/s-2001-12927 · DOI · Paper page
- Rajewsky, 1996, J. Clin. Invest., 98, 600, 10.1172/JCI118828 · DOI · Paper page
- Gu, 1994, Science, 265, 103, 10.1126/science.8016642 · DOI · Paper page
- Shimomura, 1998, J. Biol. Chem., 273, 35299, 10.1074/jbc.273.52.35299 · DOI · Paper page
- Sheng, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 935, 10.1073/pnas.92.4.935 · DOI · Paper page
- Shimano, 1996, J. Clin. Invest., 98, 1575, 10.1172/JCI118951 · DOI · Paper page
- Shimano, 1997, J. Clin. Invest., 100, 2115, 10.1172/JCI119746 · DOI · Paper page
- Mziaut, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 8883, 10.1073/pnas.97.16.8883 · DOI
- Leung, 2000, J. Biol. Chem., 275, 7515, 10.1074/jbc.275.11.7515 · DOI · Paper page
- Gilman, 1993, 1, 4.7.1
- Ohkawa, 1979, Anal. Biochem., 95, 351, 10.1016/0003-2697(79)90738-3 · DOI · Paper page
- Leclercq, 2000, J. Clin. Invest., 105, 1067, 10.1172/JCI8814 · DOI · Paper page
- Tabor, 1998, J. Biol. Chem., 273, 22052, 10.1074/jbc.273.34.22052 · DOI · Paper page
- Shimomura, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 13656, 10.1073/pnas.96.24.13656 · DOI · Paper page
- Shimano, 2001, Prog. Lipid Res., 40, 439, 10.1016/S0163-7827(01)00010-8 · DOI · Paper page
- Ntambi, 1999, J. Lipid Res., 40, 1549, 10.1016/S0022-2275(20)33401-5 · DOI · Paper page
- Xu, 2001, J. Biol. Chem., 276, 9800, 10.1074/jbc.M008973200 · DOI · Paper page
- Tiegs, 1992, J. Clin. Invest., 90, 196, 10.1172/JCI115836 · DOI · Paper page
- Schümann, 1998, J. Immunol., 161, 5745, 10.4049/jimmunol.161.10.5745 · DOI
- Diehl, 2000, Immunol. Rev., 174, 160, 10.1034/j.1600-0528.2002.017411.x · DOI · Paper page
- Zhang, 2000, J. Pharmacol. Exp. Ther., 293, 968
- Portolés, 1993, Biochim. Biophys. Acta, 1158, 287, 10.1016/0304-4165(93)90027-6 · DOI
- Kono, 2000, J. Clin. Invest., 106, 867, 10.1172/JCI9020 · DOI · Paper page
- Sewerynek, 1995, Eur. J. Pharmacol., 293, 327, 10.1016/0926-6917(95)90052-7 · DOI
- North, 1994, Am. J. Physiol., 267, C177, 10.1152/ajpcell.1994.267.1.C177 · DOI
- Bondy, 1995, FEBS Lett., 375, 53, 10.1016/0014-5793(95)01173-C · doi:10.1016/0014-5793(95)01173-c
- Harris, 1990, J. Clin. Invest., 86, 696, 10.1172/JCI114765 · DOI · Paper page
- Harris, 1993, J. Clin. Invest., 91, 1028, 10.1172/JCI116259 · DOI · Paper page
- Vreugdenhil, 2001, J. Clin. Invest., 107, 225, 10.1172/JCI10832 · DOI · Paper page
- Feingold, 1995, Infect. Immun., 63, 2041, 10.1128/iai.63.5.2041-2046.1995 · DOI · Paper page
- Yang, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 2557, 10.1073/pnas.94.6.2557 · DOI · Paper page
- Faggioni, 2000, Am. J. Pathol., 156, 1781, 10.1016/S0002-9440(10)65049-3 · DOI · Paper page
- Flier, 1998, Nat. Med., 4, 1124, 10.1038/2619 · DOI
- Lord, 1998, Nature, 394, 897, 10.1038/29795 · DOI · Paper page
- Matarese, 2001, J. Immunol., 166, 5909, 10.4049/jimmunol.166.10.5909 · DOI · Paper page
- Unger, 2000, Int. J. Obes. Relat. Metab. Disord., 24, 28, 10.1038/sj.ijo.0801498 · DOI · Paper page
- Faggioni, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 2367, 10.1073/pnas.040561297 · DOI · Paper page
- Reeves, 1996, J. Hepatol., 25, 677, 10.1016/S0168-8278(96)80238-8 · DOI
- Poonawala, 2000, Hepatology, 32, 689, 10.1053/jhep.2000.17894 · DOI · Paper page
- White, 2001, Am. J. Respir. Cell Mol. Biol., 24, 164, 10.1165/ajrcmb.24.2.4169 · DOI
- Adamson, 1992, Arch. Biochem. Biophys., 294, 223, 10.1016/0003-9861(92)90161-O · DOI · Paper page
- Schulze-Osthoff, 1992, J. Biol. Chem., 267, 5317, 10.1016/S0021-9258(18)42768-8 · DOI · Paper page
- Goossens, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 8115, 10.1073/pnas.92.18.8115 · DOI · Paper page
- Nanji, 1994, Alcohol. Clin. Exp. Res., 18, 1024, 10.1111/j.1530-0277.1994.tb00077.x · doi:10.1111/j.1530-0277.1994.tb00077.x
- Nanji, 1994, Alcohol. Clin. Exp. Res., 18, 1280, 10.1111/j.1530-0277.1994.tb00119.x · DOI · Paper page
- DeForge, 1993, J. Biol. Chem., 268, 25568, 10.1016/S0021-9258(19)74429-9 · DOI · Paper page
- Lee, 1999, J. Interferon Cytokine Res., 19, 761, 10.1089/107999099313613 · DOI
- Casola, 2001, J. Biol. Chem., 276, 19715, 10.1074/jbc.M101526200 · DOI · Paper page
- Matsuda, 2001, Genes Dev., 15, 1206, 10.1101/gad.891301 · DOI · Paper page
Cited by
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
“The accumulation of triglyceride as lipid droplets in NASH is orchestrated by a complex array of facilitating proteins(125) and factors that impair this process, predisposing to lipotoxic injury and defects in insulin signaling in cell culture(23,28,126) and in animal studies.(22,54,127,128) Corroborating human data h…”
BackgroundMolecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
Cardiac Lipid Accumulation Associated with Diastolic Dysfunction in Obese Mice
Christoffersen, C., Bollano, E., Lindegaard, M. L. S., Bartels, E. D., Goetze, J. P., Andersen, C. B., & Nielsen, L. B. (2003) · Endocrinology · doi:10.1210/en.2003-0242 · Cited by 375
Hepatic steatosis in obese patients: clinical aspects and prognostic significance
Festi, D., Colecchia, A., Sacco, T., Bondi, M., Roda, E., & Marchesini, G. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00126.x · Cited by 312
Metadata
- Authors
- Björkegren, J., Beigneux, A., Bergo, M. O., Maher, J. J., & Young, S. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 7
- Pages
- 5476-5483
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2032779971
- Cited by
- 73
- References
- 4
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6901 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.